Eprontia Oral Solution Approved for Partial-Onset, Primary Generalized Tonic-Clonic Seizures
Eprontia is approved for the treatment of partial-onset or primary generalized tonic-clonic seizures and migraine prevention.
All articles by Chen Fang, PharmD, RPh
Topical Capsaicin Spray Assessed for Sensory Neuropathic Cough
To assess the benefits of topical capsaicin on SNC, the study authors performed a retrospective review that included 253 patients.
Novel Nasal Saline Irrigation System Improves Compliance, Allergic Rhinitis Symptoms
Study authors evaluated the impact on compliance and SNOT-20 scores in patients with allergic rhinitis using a novel sinus nasal rinse device.
Multimodel Anesthesia May Cut Opioid Usage After Head and Neck Cancer Surgery
Study authors analyzed the safety and efficacy of using MMA for patients undergoing head and neck surgery.
Steroid Regimens Compared in Patients With Chronic Rhinosinusitis Without Nasal Polyps
Study authors conducted a prospective randomized trial to determine if there is a role for oral steroids in patients who have CRSsNP.
Ibuprofen Does Not Appear to Increase Posttonsillectomy Hemorrhage Severity
Study authors conducted a retrospective cohort study of pediatric patients requiring operative control of PTH.
Adding Prednisone to Pain Regimens May Reduce Opioid Use After Oropharyngeal Surgery
Study authors assessed whether the addition of a prednisone taper could decrease opioid use in patients undergoing tonsillectomy, tonsillectomy and adenoidectomy, or expansion sphincter pharyngoplasty.
Treating Chronic Rhinosinusitis With Nasal Polyps: Areas of Improvement Identified
Study authors conducted a retrospective analysis over a 5-year period to analyze health care resource utilization among CRSwNP patients and identify areas for quality improvement.
Osteoarthritis, NSAID Allergy Are Risk Factors for Opioid Use Disorder
Researchers assessed whether patients with osteoarthritis and NSAID allergies have higher odds of developing opioid use disorder, and identified next steps to be considered for this patient population.
Atopic Dermatitis Does Not Appear to Affect COVID-19 Severity
Investigators evaluated the relationship between atopic dermatitis and frequency of severity markers in patients hospitalized with COVID-19.
